Hilcrest Medical Building is categorized under Health Services in Cleveland, OH and active since 2011.
Hilcrest Medical Building was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Esti G Gumpertz at the company’s single location by writing to 6801 Mayfield Road # 244, Cleveland, Ohio OH 44124 or by phoning (440) 646-1600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hilcrest Medical Building |
| Contact Person: | Esti G Gumpertz |
| Address: | 6801 Mayfield Road # 244, Cleveland, Ohio 44124 |
| Phone Number: | (440) 646-1600 |
| Website Address: | atriumdermatology.com |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Hilcrest Medical Building was started in 2011 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Esti G Gumpertz for inquiries that concern Hilcrest Medical Building by calling the company number (440) 646-1600, as your correspondence is most welcome. Additionally, the physical location of the single location of Hilcrest Medical Building can be found at the coordinates 41.520287,-81.433387 as well as the street address 6801 Mayfield Road # 244 in Cleveland, Ohio 44124.
For its online presence, you may visit Hilcrest Medical Building’s website at atriumdermatology.com and engage with its social media outlets through on Twitter and on Facebook.